Keurig Green Mountain Inc (NASDAQ:GMCR) shares are up almost 19% in pre-market trading this morning following its Q4 earnings release yesterday after market …
H.C.
It’s one of the most elusive events in biotech: the liquidation. But after a trial failure of epic proportions – and a collapse in …
Celldex Therapeutics, Inc. (NASDAQ:CLDX) shares rose more than +10% in pre-market trading to $32.
It’s happened – the first high-profile failure from the re-emerging cohort of publicly traded gene therapy developers. Celladon Corp (NASDAQ:CLDN) reported on Sunday …
Another rough and tumble week ending with the SP 500 down sharply 3 straight days ending the week around 1994, just 4 points …